TY  - RPRT
TI  - Study on H3K9 acetylation modification and TLR9 immune regulation mechanism in patients with anti-HBV treatment using thymosin a1 combined with entecavir
AU  - v, H.-P.
AU  - Wang, K.
AU  - Du, W.
AU  - Cao, H.-H.
AU  - Zhong, Q.-Y.
AU  - Yin, S.-C.
AU  - Zhong, J.-B.
AU  - Li, F.-W.
PY  - 2020
DO  - 10.1101/2020.10.31.363127
UR  - https://www.biorxiv.org/content/10.1101/2020.10.31.363127v1
ID  - 10.1101/2020.10.31.363127
ER  -